← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2003Last known activity
Nov 30, 2020
Timeline
1980s
- Jan 1, 1983
The Rogosin Institute— Founded
Drugs by trial phase (11 distinct, 11 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Recent trials (18)
- NCT04571619CollaboratorPhase 2Nov 30, 2020
- NCT03567837Overall official - principal investigatorN/AAug 13, 2018
- NCT03567837Lead sponsorN/AAug 13, 2018
- NCT03229265Lead sponsorPhase 4Aug 1, 2017
- NCT03229265Overall official - principal investigatorPhase 4Aug 1, 2017
- NCT02595723CollaboratorEarly Phase 1Jul 1, 2015
- NCT02046174Study directorPhase 2Jan 1, 2014
- NCT02046174Lead sponsorPhase 2Jan 1, 2014
- NCT01562782Lead sponsorN/AApr 2, 2012
- NCT01562782Overall official - principal investigatorN/AApr 2, 2012
- NCT01169857Lead sponsorPhase 4Aug 1, 2010
- NCT01169857Overall official - principal investigatorPhase 4Aug 1, 2010
- NCT01103778Lead sponsorPhase 4Jul 1, 2010
- NCT01103778Overall official - principal investigatorPhase 4Jul 1, 2010
- NCT00627861Lead sponsorN/ANov 1, 2008
Details
- Founded
- New York City, NY, US Jan 1, 1983
- Last known activity
- Nov 30, 2020